α-Synuclein seeding activity in duodenum biopsies from Parkinson's disease patients

PLoS Pathog. 2023 Jun 30;19(6):e1011456. doi: 10.1371/journal.ppat.1011456. eCollection 2023 Jun.

Abstract

Abnormal deposition of α-synuclein is a key feature and biomarker of Parkinson's disease. α-Synuclein aggregates can propagate themselves by a prion-like seeding-based mechanism within and between tissues and are hypothesized to move between the intestine and brain. α-Synuclein RT-QuIC seed amplification assays have detected Parkinson's-associated α-synuclein in multiple biospecimens including post-mortem colon samples. Here we show intra vitam detection of seeds in duodenum biopsies from 22/23 Parkinson's patients, but not in 6 healthy controls by RT-QuICR. In contrast, no tau seeding activity was detected in any of the biopsies. Our seed amplifications provide evidence that the upper intestine contains a form(s) of α-synuclein with self-propagating activity. The diagnostic sensitivity and specificity for PD in this biopsy panel were 95.7% and 100% respectively. End-point dilution analysis indicated up to 106 SD50 seeding units per mg of tissue with positivity in two contemporaneous biopsies from individual patients suggesting widespread distribution within the superior and descending parts of duodenum. Our detection of α-synuclein seeding activity in duodenum biopsies of Parkinson's disease patients suggests not only that such analyses may be useful in ante-mortem diagnosis, but also that the duodenum may be a source or a destination for pathological, self-propagating α-synuclein assemblies.

MeSH terms

  • Biopsy
  • Duodenum
  • Humans
  • Intestines
  • Parkinson Disease* / diagnosis
  • alpha-Synuclein

Substances

  • alpha-Synuclein

Grants and funding

This work was partially supported by Intramural Research Program of the National Institute for Allergy and Infectious Diseases, National Institutes of Health (BC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CDO, BRG, SP, AGH, CLH and BC received a salary from Intramural Research Program of the National Institute for Allergy and Infectious Diseases, National Institutes of Health.